Top Markets
#1 DogBull DogBull +132.53%
#2 Harmony Harmony +116.31%
#3 Akedo Akedo +56.16%
#4 Zama Zama +46.52%
#5 Bedrock Bedrock +42.53%
#6 Derive Derive +33.60%
#7 Celer Network Celer Network +33.47%
#8 Gravity Gravity +30.25%
#9 Epic Chain Epic Chain +27.76%
#10 OpenServ OpenServ +27.30%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
GSK plc GSK plc

GSK plc

GSK
Rank in Stocks #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Share Price
$25.28
Last synced: 2026-09-18
Market Cap
$1.01B
Change (1 day)
-2.29%
Change (1 year)
-37.84%
Country
GB
Trade GSK plc (GSK)

Category

Healthcare
Revenue for GSK plc (GSK)
Revenue in Jun 2026 TTM: $45.18B
According to GSK plc latest financial reports the company's current revenue (TTM) is $45.18B. In 2024 the company made a revenue of $39.37B an increase over the revenue in the year 2023 that was $38.61B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for GSK plc from 2000 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $45.18B 5.15%
2025 $42.97B 9.13%
2024 $39.37B 1.98%
2023 $38.61B 8.83%
2022 $35.48B 6.25%
2021 $33.39B 0.28%
2020 $33.30B -25.61%
2019 $44.76B 14.02%
2018 $39.26B -3.77%
2017 $40.79B 18.52%
2016 $34.42B -2.36%
2015 $35.25B -1.64%
2014 $35.84B -18.35%
2013 $43.90B 2.38%
2012 $42.87B 0.88%
2011 $42.50B -3.83%
2010 $44.19B -3.75%
2009 $45.91B 29.14%
2008 $35.55B -21.53%
2007 $45.31B -0.48%
2006 $45.53B 22.17%
2005 $37.27B -2.94%
2004 $38.40B 0.32%
2003 $38.27B 12.00%
2002 $34.17B 14.47%
2001 $29.85B 10.60%
2000 $26.99B 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B 76.33%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B 116.76%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B 42.51%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B 71.58%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B 46.97%
US